13F Filings History of HealthCor Management, L.P.
- Latest 13F filing
- Q4 2022 - 15 Feb 2023
- Latest reported 13F value
- $109,111,523
- Largest 13F holdings
-
BMRN DXCM CYTK ACRV HYPR ALKS CNMD NBIX SNDX KDNY ISRG BPMC
+8 more
GERN PEN RCKT RAIN INSP SILK IMGN EQRXW - Form 13F summary
-
- HealthCor Management, L.P. Form 13F history summarizes parsed U.S.-listed equity disclosures for this manager.
- Form 13F is generally due within 45 days after each calendar quarter ends.
- HealthCor Management, L.P. reported 22 equity holdings with a total reported market value of $109,111,523 for Q4 2022. Top reported holdings included BMRN, DXCM, CYTK, ACRV, and HYPR.
- Manager signature
- Arthur Cohen - Partner and Co-CEO
- Manager location
- New York, NY
13F snapshot
Latest parsed holdings, value, and filing-period context.
1 signal
Manager
Names, identifiers, and filing context for this profile.
2 identity fields
Follow Filing Activity
Follow HealthCor Management, L.P. with Pro and return when a new 13F portfolio filing changes the record on this page.
Pro alert delivery is coming soon and remains tied to source-backed filing changes rather than inferred market advice.
Holdings Value
Form 13F evidence
Quarterly portfolio filings
SEC-reported 13F quarters for this filer, ordered by the latest accepted filing.
Latest quarter
Q4 2022
Latest value
$109,111,523
Quarter delta
-$690,465,477
Accepted
14 Feb 2023, 17:44
Rows shown
1-25 of 37
| Quarter | Holdings | SEC-reported value | Bought | Sold | Net | Top Holdings | Form Type | Accepted by SEC |
|---|---|---|---|---|---|---|---|---|
| Q4 2022 | 22 | $109,111,523 | +$18,739,598 | -$737,569,108 | -$718,829,510 | BMRN, DXCM, CYTK, ACRV, HYPR | 13F-HR | 14 Feb 2023, 17:44 |
| Q3 2022 | 58 | $799,577,000 | +$246,949,103 | -$437,250,314 | -$190,301,211 | BMRN, ABBV, A, BSX, LLY | 13F-HR | 14 Nov 2022, 12:55 |
| Q2 2022 | 55 | $971,604,000 | +$200,268,397 | -$567,308,285 | -$367,039,888 | BIIB, HZNP, BSX, BMRN, CNC | 13F-HR | 15 Aug 2022, 12:14 |
| Q1 2022 | 63 | $1,445,162,000 | +$487,461,583 | -$830,132,450 | -$342,670,867 | BIIB, BSX, HZNP, BMRN, NTRA | 13F-HR | 16 May 2022, 12:35 |
| Q4 2021 | 66 | $1,809,021,000 | +$563,866,902 | -$1,057,359,987 | -$493,493,085 | MDT, BMY, BIIB, HZNP, NVST | 13F-HR | 14 Feb 2022, 12:24 |
| Q3 2021 | 72 | $2,299,105,000 | +$841,325,622 | -$945,989,597 | -$104,663,975 | BMY, HZNP, BIIB, COR, WOOF | 13F-HR | 15 Nov 2021, 13:16 |
| Q2 2021 | 69 | $2,436,596,000 | +$1,077,172,392 | -$1,453,253,496 | -$376,081,104 | ZBH, BIIB, HZNP, WOOF, REGN | 13F-HR | 16 Aug 2021, 12:21 |
| Q1 2021 | 78 | $2,688,758,000 | +$1,393,731,177 | -$1,294,741,864 | +$98,989,313 | HZNP, VRTX, ZBH, DHR, HUM | 13F-HR | 17 May 2021, 12:37 |
| Q4 2020 | 49 | $2,465,508,000 | +$1,037,815,696 | -$1,237,467,753 | -$199,652,057 | HZNP, IQV, VRTX, COO, HCA | 13F-HR | 16 Feb 2021, 14:12 |
| Q3 2020 | 38 | $2,466,894,000 | +$1,132,100,018 | -$1,145,837,128 | -$13,737,110 | ZBH, UNH, MDT, HZNP, MDGL | 13F-HR | 16 Nov 2020, 14:12 |
| Q2 2020 | 50 | $2,386,913,000 | +$1,091,167,881 | -$1,460,516,634 | -$369,348,753 | AUPH, BDX, MDGL, ABBV, NVRO | 13F-HR | 14 Aug 2020, 12:47 |
| Q1 2020 | 45 | $2,326,255,000 | +$1,278,428,497 | -$1,202,198,406 | +$76,230,091 | NVRO, HAE, AUPH, LH, NBIX | 13F-HR | 15 May 2020, 12:28 |
| Q4 2019 | 52 | $2,766,773,000 | +$1,339,542,277 | -$1,359,406,323 | -$19,864,046 | LH, REGN, NVRO, HOLX, TFX | 13F-HR | 14 Feb 2020, 13:03 |
| Q3 2019 | 50 | $2,497,233,000 | +$807,485,339 | -$797,633,984 | +$9,851,355 | EW, NBIX, MRK, ISRG, VRTX | 13F-HR | 14 Nov 2019, 13:42 |
| Q2 2019 | 50 | $2,528,463,000 | +$1,262,186,591 | -$1,152,494,683 | +$109,691,908 | NBIX, HUM, EW, MRK, MDGL | 13F-HR | 14 Aug 2019, 13:16 |
| Q1 2019 | 45 | $2,368,183,000 | +$1,073,743,601 | -$1,610,086,074 | -$536,342,473 | DHR, UNH, ZBH, MDT, NBIX | 13F-HR | 15 May 2019, 13:01 |
| Q4 2018 | 36 | $2,719,078,000 | +$1,336,125,390 | -$1,312,766,884 | +$23,358,506 | ISRG, DXCM, REGN, DHR, CVS | Restatement | 14 Feb 2019, 15:22 |
| Q3 2018 | 41 | $3,015,332,000 | +$951,781,296 | -$1,284,977,970 | -$333,196,674 | ZBH, MRK, MDT, REGN, SYK | 13F-HR | 15 Nov 2018, 12:49 |
| Q2 2018 | 44 | $3,043,352,000 | +$1,092,618,474 | -$1,004,605,106 | +$88,013,368 | MRK, REGN, ZBH, LH, ELV | 13F-HR | 14 Aug 2018, 13:11 |
| Q1 2018 | 43 | $2,825,793,000 | +$1,219,413,804 | -$1,405,665,189 | -$186,251,385 | ZBH, REGN, MRK, LH, XRAY | 13F-HR | 15 May 2018, 13:04 |
| Q4 2017 | 36 | $3,060,454,000 | +$1,377,349,808 | -$860,854,284 | +$516,495,524 | MRK, BIVV, ZBH, CELG, LH | 13F-HR | 14 Feb 2018, 14:32 |
| Q3 2017 | 34 | $2,582,328,000 | +$921,134,152 | -$1,074,121,914 | -$152,987,762 | LH, BIVV, ZBH, AET, NBIX | 13F-HR | 14 Nov 2017, 13:55 |
| Q2 2017 | 35 | $2,668,265,000 | +$1,181,649,970 | -$906,652,374 | +$274,997,596 | BIVV, CELG, LH, EW, AET | 13F-HR | 14 Aug 2017, 11:53 |
| Q1 2017 | 36 | $2,179,695,000 | +$1,165,084,519 | -$867,768,745 | +$297,315,774 | BIVV, AET, CELG, LH, EW | 13F-HR | 15 May 2017, 11:56 |
| Q4 2016 | 37 | $1,742,025,000 | +$1,031,126,694 | -$864,229,315 | +$166,897,379 | CELG, LH, ISRG, AET, DGX | 13F-HR | 14 Feb 2017, 11:46 |